US FTC Targets Fake Online Reviews, Expanded Liability, With Proposed Endorsement Guides Update
Proposed changes to the FTC’s “Guides Concerning the Use of Endorsements and Testimonials in Advertising” depict an agency looking to crack down on fake reviews and suppression of negative ones, tighten its definition of “clear and conspicuous” disclosures, and clarify that advertisers, endorsers, intermediaries and platforms all can be held liable for their endorsement roles.
You may also be interested in...
NMN Supplement Firm Works On Disclosing Sales Relationships With Advertising Affiliates
Renue By Science agrees with National Advertising Division recommendations to “clearly and conspicuously disclose” material connections in online advertising by employees, nonprofits and others offering sales to its supplements containing nicotinamide mononucleotide, quercetin or resveratrol.
FTC Expands Dietary Supplement Advertising Guidance To All Products Making Health-Related Claims
The Federal Trade Commission’s Health Products Compliance Guidance, published 20 December, expands the agency’s focus from dietary supplements to all products making health-related claims, providing the first update in 25 years on the FTC’s thinking on clear and conspicuous disclosures and competent and reliable scientific evidence.
FTC Weighing Trade Rule On Fake Endorsements, Including By ‘Patient Ambassadors’
If the commission does develop a rule, it would provide a vehicle for stronger enforcement in the area.